Will AB InBev's Premium Mix Strategy Finally Backfire When Volume Pressure Returns?

Anheuser-Busch InBev (BUD) reports first-quarter 2026 earnings on May 5, with analysts expecting $0.90 per share—an 11% jump from the prior-year quarter. The central question: can the world's largest brewer sustain its recent momentum of consistent earnings beats while navigating volume pressures and regional headwinds? With the stock trading near $73.91 and Wall Street's consensus price target at $87.20, the stakes are high for a company that has topped estimates in each of the past four quarters.

Part 1: Earnings Preview

Anheuser-Busch InBev is the world's largest brewer, producing iconic brands including Budweiser, Stella Artois, and Corona across more than 50 countries. The company operates through six geographic segments—North America, Middle Americas, South America, EMEA, Asia Pacific, and Global Export—generating approximately $59 billion in annual revenue.

BUD reports Q1 2026 earnings on May 5, before market open, with the consensus estimate at $0.90 per share from four analysts. The most recently reported quarter (Q4 2025) delivered $0.95 per share, beating the $0.92 estimate by 3.26%. Year-over-year, the Q1 2026 estimate represents an 11.11% increase from the $0.81 reported in Q1 2025, signaling expectations for solid growth despite ongoing volume challenges.

Three key themes define this earnings story:

Volume Stabilization vs. Premiumization Trade-off: Analysts are watching whether BUD can offset declining volumes—particularly in key markets like North America and Asia Pacific—with continued revenue per hectoliter growth driven by premium brand mix and pricing power. The Middle Americas and EMEA regions are expected to show volume strength, but the critical question is whether premiumization can sustain double-digit earnings growth when total volumes remain under pressure.

Regional Performance Divergence: Wall Street expects Middle Americas revenue to reach $4.32 billion (up 14.1% year-over-year) and EMEA to hit $2.25 billion (up 14.5%), while North America is projected at $3.42 billion (up just 1.6%) and Asia Pacific at $1.40 billion (down 3.1%). The geographic split will determine whether BUD's growth story remains intact or if weakness in developed markets begins to weigh on the overall narrative.

Margin Expansion and Cost Management: With EBITDA reaching $5.47 billion in the most recent period and operating profit at $4.52 billion, investors are focused on whether BUD can continue expanding margins through operational efficiency and favorable input costs, even as marketing spend remains elevated to support brand positioning.

Evercore ISI and Wells Fargo both maintained their ratings in February 2026 following the Q4 release, while Goldman Sachs upgraded the stock in May 2025. Analysts are particularly focused on management's commentary around volume trends in China and the U.S., where consumer behavior remains uncertain, and whether the company can sustain its recent track record of beating estimates by 2-5% each quarter.

Part 2: Historical Earnings Performance

Anheuser-Busch InBev has established a consistent pattern of exceeding analyst expectations, beating estimates in each of the past four quarters. The beats have ranged from 2.06% to 5.19%, with an average surprise of approximately 3.7%. This track record suggests the company has either been conservative in guiding expectations or has executed better than anticipated on operational efficiency and pricing.

The magnitude of beats has been relatively stable, with Q1 2025 delivering the largest upside surprise at 5.19% ($0.81 vs. $0.77 estimate), while Q3 2025 showed the smallest at 2.06% ($0.99 vs. $0.97 estimate). The most recent quarter (Q4 2025) came in at $0.95 versus the $0.92 estimate, a 3.26% beat that continued the positive trend. Notably, reported earnings have shown sequential improvement from Q1 to Q3 2025 ($0.81 to $0.99), though Q4 saw a typical seasonal decline to $0.95.

The consistency of these beats—four consecutive quarters without a miss—suggests BUD has developed credibility with the Street and may have room to surprise again in Q1 2026. However, the year-over-year comparison shows Q1 2025's $0.81 was the weakest quarter of the year, making the 11% growth expectation for Q1 2026 both achievable based on recent momentum and necessary to maintain the growth trajectory.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

BUD typically reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through or reversal dynamics.

Historical price behavior around earnings shows significant volatility, with an average absolute Day 0 move of 5.19% and Day 0 range of 2.16%. The direction has been mixed: the most recent report (February 2026) saw a strong +3.81% Day 0 gain, while July 2025 produced a dramatic -13.33% decline—the largest move in the dataset. Day +1 follow-through has been more muted, averaging 1.10% with a 1.76% range, suggesting most of the price discovery occurs in the immediate reaction.

The pattern reveals that BUD can move sharply in either direction depending on the quality of the beat and forward guidance. Positive surprises like February 2026 (+3.81%) and February 2025 (+7.21%) generated strong rallies, while October 2024 (-5.63%) and July 2025 (-13.33%) showed the stock is vulnerable to sharp selloffs when results or outlook disappoint. Investors should prepare for a potential 4-6% move on earnings day, with the direction heavily dependent on whether BUD can maintain its recent streak of beats and provide constructive commentary on volume trends.

Part 2.2: Options Market Expected Move

The options market is pricing a 5.04% expected move through the May 8 weekly expiration, slightly below the 5.19% average absolute Day 0 move observed historically. This suggests options traders are anticipating a typical earnings reaction rather than an outsized move, though the historical range shows BUD is capable of moves well above (February 2025's +7.21%) or below (July 2025's -13.33%) this level depending on the magnitude of any surprise.

Part 3: What Analysts Are Saying

Wall Street maintains a bullish stance on BUD heading into earnings, with an average recommendation of 4.41 on the 5-point scale, firmly in buy territory. The consensus includes 14 Strong Buy ratings, 3 Moderate Buys, and 5 Holds, with zero sell ratings. This 22-analyst consensus has remained unchanged over the past month, indicating stable conviction despite the upcoming earnings event.

The average price target of $87.20 implies 18% upside from the current price of $73.91, with a wide range spanning from a low of $70.00 to a high of $100.00. The high-end target suggests some analysts see potential for significant appreciation if BUD can demonstrate sustained volume stabilization and margin expansion, while the low-end target sits just below current levels, reflecting caution around execution risks in key markets.

Recent analyst activity has been supportive: Goldman Sachs upgraded the stock in May 2025, while Evercore ISI and Wells Fargo maintained their positive ratings following the February 2026 Q4 report. Wells Fargo initiated coverage in November 2025, adding to the bullish chorus. The lack of downgrades and stable sentiment trend suggest analysts are comfortable with BUD's current trajectory and believe the risk/reward remains favorable even after the stock's recent performance.

Part 4: Technical Picture

The Barchart Technical Opinion shows strengthening momentum heading into earnings, with the signal improving from 56% Buy one month ago to 72% Buy one week ago, and further to 88% Buy currently. This progressive strengthening indicates building technical conviction as the stock approaches the earnings release.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal suggests near-term momentum is positive but not overwhelming, reflecting some consolidation after recent gains
• Medium-term (100% Buy): Strong buy signal across all medium-term indicators points to solid intermediate-term trend strength supporting the current move
• Long-term (100% Buy): Unanimous buy signal in the longer-term timeframe confirms the broader uptrend remains intact and provides a supportive backdrop for earnings

Trend Characteristics: The combination of Good strength and Average direction suggests BUD is in a healthy uptrend with solid momentum, though not yet in an overextended or parabolic phase that might be vulnerable to profit-taking on earnings.

The stock is currently trading at $73.91, positioned above the 10-day ($73.53), 50-day ($73.43), 100-day ($71.25), and 200-day ($66.43) moving averages, but below the 5-day ($74.45) and 20-day ($74.24) averages. This configuration suggests BUD is in a consolidation phase within a broader uptrend, having pulled back slightly from recent highs while maintaining support above key intermediate and long-term moving averages. The technical setup is generally supportive heading into earnings, with the stock holding above critical support levels and the overall trend structure intact. However, the slight pullback from the 5-day and 20-day averages suggests the market may be waiting for the earnings catalyst to determine the next directional move, making the quality of the report and guidance particularly important for confirming the bullish technical picture.